139 related articles for article (PubMed ID: 9951975)
1. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board.
Halsey NA; Duclos P; Van Damme P; Margolis H
Pediatr Infect Dis J; 1999 Jan; 18(1):23-4. PubMed ID: 9951975
[No Abstract] [Full Text] [Related]
2. [Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!].
Costagliola D
Rev Epidemiol Sante Publique; 2008 Dec; 56(6):379-81. PubMed ID: 19019601
[No Abstract] [Full Text] [Related]
3. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.
Demicheli V; Rivetti A; Di Pietrantonj C; Clements CJ; Jefferson T
J Viral Hepat; 2003 Sep; 10(5):343-4. PubMed ID: 12969184
[No Abstract] [Full Text] [Related]
4. Hepatitis B vaccine and risk of multiple sclerosis.
DeStefano F; Verstraeten T; Chen RT
Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis and hepatitis B vaccine?
Hall A; Kane M; Roure C; Meheus A
Vaccine; 1999 Jun; 17(20-21):2473-5. PubMed ID: 10418891
[No Abstract] [Full Text] [Related]
6. Systemic adverse effects of hepatitis B vaccines are rare.
Prescrire Int; 2004 Dec; 13(74):218-23. PubMed ID: 15612143
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis B vaccine and demyelinating diseases: debate and disinformation].
Pol S
Presse Med; 2009 Apr; 38(4):519-23. PubMed ID: 19201152
[No Abstract] [Full Text] [Related]
8. [Controversy about a vaccine].
Criel C
Soins Psychiatr; 1998; (197):suppl IV. PubMed ID: 9775976
[No Abstract] [Full Text] [Related]
9. [Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998)].
Soubeyrand B; Boisnard F; Bruel M; Debois H; Delattre D; Gauthier A; Soum S; Thébault C
Presse Med; 2000 Apr; 29(14):775-80. PubMed ID: 10816715
[TBL] [Abstract][Full Text] [Related]
10. [Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response].
Confavreux C; Vukusic S; Arbizu T; Brochet B; Clanet M; Edan G; Kappos L; Suissa S
Rev Neurol (Paris); 2005 Jul; 161(6-7):644-6; author reply 646-7. PubMed ID: 16145827
[No Abstract] [Full Text] [Related]
11. Continue to vaccinate against hepatitis B.
Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype.
Kaplanski G; Retornaz F; Durand J; Soubeyrand J
J Neurol Neurosurg Psychiatry; 1995 Jun; 58(6):758-9. PubMed ID: 7608688
[No Abstract] [Full Text] [Related]
13. [Pharmacovigilance of hepatitis B vaccines].
Imbs JL; Decker N; Welsch M
Bull Acad Natl Med; 2003; 187(8):1489-98; discussion 1498-500. PubMed ID: 15146580
[TBL] [Abstract][Full Text] [Related]
14. Drug firm compensates patients for suspected hepatitis B vaccine failure.
Durand de Bousingen D
Lancet; 2001 May; 357(9268):1598. PubMed ID: 11377660
[No Abstract] [Full Text] [Related]
15. Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Martínez-Sernández V; Figueiras A
J Neurol; 2013 Aug; 260(8):1951-9. PubMed ID: 23086181
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
Mouchet J; Bégaud B
Vaccine; 2019 Apr; 37(15):2142-2148. PubMed ID: 30851966
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation.
Jefferson T; Traversa G
J Med Virol; 2002 Jul; 67(3):451-3. PubMed ID: 12116044
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B vaccine tolerance: spontaneous reporting and pharmacoepidemiologic studies].
Autret-Leca E; Bensouda-Grimaldi L; Jonville-Bera AP; Beau-Salinas F
Presse Med; 2007 Apr; 36(4 Pt 1):563-4. PubMed ID: 17329069
[No Abstract] [Full Text] [Related]
19. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.
Touzé E; Fourrier A; Rue-Fenouche C; Rondé-Oustau V; Jeantaud I; Bégaud B; Alpérovitch A
Neuroepidemiology; 2002; 21(4):180-6. PubMed ID: 12065880
[TBL] [Abstract][Full Text] [Related]
20. [Vaccination against hepatitis B and the risk of multiple sclerosis].
Magdzik W; Zieliński A
Przegl Epidemiol; 2005; 59(1):11-9. PubMed ID: 16013405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
